Program
The Role of the Nurse Navigator for Cardiac Amyloidosis
May 24, 2024 from 11:00am MDT to 11:30am MDT
This presentation highlights the critical role of a nurse navigator in the comprehensive care of patients with cardiac amyloidosis. As an often underdiagnosed and challenging condition, cardiac amyloidosis requires a multidisciplinary approach for effective detection, management, and treatment. The nurse navigator is integral in this process, ensuring seamless coordination and support throughout the patient journey.
The presentation begins with an overview of cardiac amyloidosis, emphasizing its unique diagnostic complexities and impact on cardiovascular health. The nurse navigator’s role in early detection is explored and focuses on facilitating timely and appropriate diagnostic tests, collaboration with specialists, and communication with patients and their families.
The importance of the nurse navigator becomes evident in the realm of patient education and emotional support. By providing clear and accessible information about cardiac amyloidosis, treatment options, and potential challenges, the nurse navigator empowers patients to participate in their care decisions actively.
Moreover, the presentation addresses the nurse navigator’s pivotal role in coordinating care among various healthcare providers, ensuring a cohesive and patient-centric treatment plan. This includes liaising with cardiologists, hematologists, and other specialists and guiding patients through complex treatment regimens, diuretic sliding scales, novel therapies, and clinical trials.
Ultimately, the nurse navigator emerges as a crucial advocate for patients with cardiac amyloidosis, promoting adherence to treatment plans, monitoring for potential complications, and offering ongoing support. This presentation underscores the invaluable contribution of nurses in optimizing patient outcomes and improving the overall quality of care for individuals facing the challenges of cardiac amyloidosis.